Cushing Capital Partners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.65M Buy
6,221
+152
+3% +$40.1K 1.01% 29
2026
Q2
$1.54M Sell
6,069
-92
-1% -$21.4K 1.06% 29
2026
Q1
$1.51M Sell
6,161
-1,182
-16% -$275K 1.16% 28
2025
Q4
$1.52M Sell
7,343
-271
-4% -$53.6K 1.13% 29
2025
Q3
$1.41M Buy
7,614
+5,440
+250% +$932K 1.11% 28
2025
Q2
$332K Buy
2,174
+14
+0.6% +$2.15K 0.28% 70
2025
Q1
$358K Buy
2,160
+13
+0.6% +$2.03K 0.32% 67
2024
Q4
$310K Buy
+2,147
New +$333K 0.3% 67

Other funds holding JNJ

Cushing Capital Partners's JNJ Position: Q3 2026 in Review

Cushing Capital Partners increased its Johnson & Johnson (JNJ) stake by 2.5% in Q3 2026, buying an estimated $40.1K and bringing the position to 6,221 shares worth $1.65M. The position accounts for 1.01% of the portfolio, ranked #29.

Cushing Capital Partners first reported a position in JNJ in Q4 2024 and has held it in 8 quarters since. 3,177 funds tracked by Wall St. Rank hold JNJ as of Q3 2026.

  • Cushing Capital Partners held 6,221 shares of Johnson & Johnson worth $1.65M as of Q3 2026.
  • Cushing Capital Partners bought 152 Johnson & Johnson shares in Q3 2026, an estimated $40.1K.
  • Johnson & Johnson made up 1.01% of Cushing Capital Partners's portfolio in Q3 2026, its #29 holding.
  • Cushing Capital Partners first reported a position in Johnson & Johnson in Q4 2024 and has held it in 8 quarters since.
  • 3,177 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2026.

Based on Cushing Capital Partners's 13F filing for Q3 2026, filed 20 Oct 2026.